Pancreatic cancer trials in Belgium
35 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 Nov 2026. Ask the study team whether a trial fits you.
Phase 2/3RecruitingResearch participation
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
- Where
- Edegem, Ghent, Leuven
- Age
- 18 years and over
- People
- 109
- Run by
- KU Leuven
See details and how to joinNCT06782412Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Bonheiden, Edegem, Leuven
- Age
- 18 years and over
- People
- 570 worldwide
- Run by
- Immuneering Corporation
See details and how to joinNCT07562152EU 2026-525617-31-00Registry updated 2026-11-06
Phase 2RecruitingTrial-stage medicine
A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Where
- Brussels, Ghent
- Age
- 18 years and over
- People
- 254 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07492680Registry updated 2026-11-04
Phase 2/3RecruitingTrial-stage medicine
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Brussels, Edegem, Leuven, Woluwe-Saint-Lambert
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755EU 2025-521043-20-00Registry updated 2026-10-30
Phase 3RecruitingTrial-stage medicine
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Where
- Anderlecht, Brussels, Edegem, Ghent, Gilly, Leuven, Liège, Yvoir
- Age
- 18 years and over
- People
- 588 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT07522073Registry updated 2026-10-30
Phase 1/2RecruitingTrial-stage medicine
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
- Where
- Antwerp, Ghent, Leuven, Liège
- Age
- 18 years and over
- People
- 450 worldwide
- Run by
- Bayer
See details and how to joinNCT06914128EU 2025-520623-24-00Registry updated 2026-10-28
Phase 2/3RecruitingResearch participation
FAPIDO
- Where
- Edegem, Gent, Leuven
- Age
- 18 years and over
- People
- 109
- Run by
- UZ Leuven
See details and how to join2024-512059-19-00EU 2024-512059-19-00Registry updated 2026-10-27
Phase 2RecruitingTrial-stage medicine
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Brussels, Edegem, Ghent, Jette, Leuven
- Age
- 18 years and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478EU 2023-507641-29-00Registry updated 2026-10-26
Phase 1/2RecruitingTrial-stage medicine
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Charleroi, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064EU 2023-509632-26-00Registry updated 2026-10-26
Phase 3Not yet recruitingResearch participation
Phase 3 Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC 6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
- Where
- Anderlecht, Bonheiden, Edegem, Gent, Leuven, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 233 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524969-24-00EU 2025-524969-24-00Registry updated 2026-10-20
Phase 1/2RecruitingTrial-stage medicine
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Bonheiden, Brussels, Leuven, Roeselare
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034Registry updated 2026-10-19
Phase 2/3RecruitingTrial-stage medicine
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- Brussels, Charleroi, Leuven, Turnhout
- Age
- 18 years and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437EU 2025-522093-36-00Registry updated 2026-10-14
Phase 3RecruitingTrial-stage medicine
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Where
- Anderlecht, Bonheiden, Charleroi, Edegem, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 900 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT07491445EU 2025-525088-34-00Registry updated 2026-10-02
Phase 3RecruitingResearch participation
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Leuven
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00EU 2025-524160-38-00Registry updated 2026-10-01
Phase 3RecruitingResearch participation
Phase 3 Study of Investigator Choice of Chemotherapy with or without Zoldonrasib as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma
- Where
- Edegem, Gent, Leuven, Liège, Roeselare, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 281 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2025-524928-21-00EU 2025-524928-21-00Registry updated 2026-09-25
Phase 3RecruitingResearch participation
A Randomized, Double-Blind, Phase 3 Study of Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D–Mutated Metastatic Pancreatic Ductal Adenocarcinoma (DAWN-303)
- Where
- Anderlecht, Charleroi, Edegem, Gent, Jette, Leuven, Liège, Sint-Lambrechts-Woluwe, Yvoir
- Age
- 18 years and over
- People
- 239 worldwide
- Run by
- Incyte Corp.
See details and how to join2025-525009-18-00EU 2025-525009-18-00Registry updated 2026-09-25
Phase 4RecruitingResearch participation
Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial
- Where
- Edegem
- Age
- 18 years and over
- People
- 460 worldwide
- Run by
- Amsterdam UMC Stichting
See details and how to join2024-519667-18-00EU 2024-519667-18-00Registry updated 2026-09-17
Phase 2RecruitingResearch participation
LuMIERE: A Phase 1/2, Multicenter, Open label, Non randomized Study to Investigate Safety and Tolerability, Pharmacokinetics, Dosimetry, and Preliminary Activity of [177Lu]Lu-FAP-2286 in Participants with an Advanced Solid Tumor
- Where
- Anderlecht, Edegem, Leuven, Liège
- Age
- 18 years and over
- People
- 36 worldwide
- Run by
- Novartis Pharma AG
See details and how to joinNCT04939610EU 2023-508995-12-01Registry updated 2026-08-31
Phase 1/2RecruitingTrial-stage medicine
Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors
- Where
- Antwerp, Brussels, Liège
- Age
- 18 years and over
- People
- 230 worldwide
- Run by
- Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
See details and how to joinNCT05985655Registry updated 2026-08-13
Phase 1/2RecruitingTrial-stage medicine
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Anderlecht, Leuven
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129EU 2023-504254-35-00Registry updated 2026-08-11
Phase 1RecruitingTrial-stage medicine
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Where
- Edegem, Ghent
- Age
- 18 years and over
- People
- 434 worldwide
- Run by
- Amgen
See details and how to joinNCT07094113Registry updated 2026-07-30
Phase 1RecruitingTrial-stage medicine
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Where
- Brussels
- Age
- 18 years to 100 years
- People
- 162 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06562192Registry updated 2026-07-29
Phase 1RecruitingTrial-stage medicine
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Anderlecht
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762EU 2023-506604-18-00Registry updated 2026-07-22
Phase 1RecruitingTrial-stage medicine
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
- Where
- Brussels, Edegem, Leuven
- Age
- 18 years and over
- People
- 710 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06179160EU 2023-507091-47-00Registry updated 2026-07-22
Phase 2/3Not yet recruitingResearch participation
A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer
- Where
- Antwerp, Ghent
- Age
- 18 years and over
- People
- 95 worldwide
- Run by
- ElmediX
See details and how to joinNCT07711067Registry updated 2026-07-17
All Pancreatic cancer trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.